Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas.
about
Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its SymptomsImpact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation.Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization studyA susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosisModifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping resultsInhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.Understanding the population structure of North American patients with cystic fibrosisCystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sexAnimal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.Pancreatic phenotype in infants with cystic fibrosis identified by mutation screeningGenetic modifiers of nutritional status in cystic fibrosisAssessing the Disease-Liability of Mutations in CFTRCLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis.Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults.Diagnostic Accuracy of a Short Endoscopic Secretin Test in Patients With Cystic FibrosisCFTR functions as a bicarbonate channel in pancreatic duct cells.Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.Symposium 6: Young people, artificial nutrition and transitional care. The nutritional challenges of the young adult with cystic fibrosis: transition.A novel gene delivery method transduces porcine pancreatic duct epithelial cells.Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literature.Longitudinal cystic fibrosis care.Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations.CFTR, bicarbonate, and the pathophysiology of cystic fibrosis.Survival of Patients with Cystic Fibrosis Depending on Mutation Type and Nutritional Status.Cystic fibrosis from the gastroenterologist's perspective.Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life.High ambient temperature and risk of intestinal obstruction in cystic fibrosis.Early acute pancreatitis in a child with compound heterozygosis ∆F508/R1438W/Y1032C cystic fibrosis: a case report.Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis.Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis.Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene.Cystic fibrosis mutations for p.F508del compound heterozygotes predict sweat chloride levels and pancreatic sufficiency.Exon skipping through the creation of a putative exonic splicing silencer as a consequence of the cystic fibrosis mutation R553X.Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.Relation of Ultrasound Findings and Abdominal Symptoms obtained with the CFAbd-Score in Cystic Fibrosis Patients.
P2860
Q28077411-82DDC234-FCF1-4437-A07D-0F36E3783589Q33551857-73AD3775-72AB-4758-A55A-9D318CCF1438Q33596314-88A3EE38-53E3-47DB-A5ED-EC4040569DA3Q33646755-BD757431-0C3E-4BDE-8E48-BAF70F751440Q33880999-6A476EF3-E3DD-40E8-9111-3555E4A6DB30Q33926291-A5C4C2D7-96A2-46E2-9A12-6F65BFB2B97BQ34085307-BECB226C-12DE-41B4-9DCA-993A2A705CE8Q34243590-8193C116-36FA-4092-B8F5-B9A787BF759BQ34367715-CBAF97DB-9B1F-4238-A72B-0BF125A5B0D2Q34684122-25D8867B-3922-47E9-81D7-654E02E3B50DQ35140718-DF3B5347-9F80-43EA-8770-F640BA513E4CQ35178642-D1C4450E-D925-4CBB-B95B-3351588D02B7Q35934114-70B088D7-2494-46FD-A431-0212BB50B9F4Q36154097-3AA7DA5A-A0E6-4014-B21F-21228A27A473Q36398331-4FE55DDD-25B1-4D23-AB2F-A0AB942286F8Q36526518-C6DE5DDD-BB8D-4E69-87A4-00DC2089F648Q36667128-4602FE59-F4BF-4FB7-BE42-D4CF1E7EB394Q36842031-1E74E347-2683-4C3D-8CC0-75826C81DBEBQ37100355-F24E142E-BBAA-42F1-9FD9-4E7ED53BE7DDQ37124268-E7A23954-CC0D-4CE3-A5DD-ADE6BC3DE1CCQ37193199-8DBE24E4-AD9B-439E-965C-0302943D55DBQ37304358-09FF3C1C-B3D5-4008-8DEF-44DE3982451CQ37583973-8DAA599D-ED81-44CD-BCF7-B3D6362D74C2Q37624228-1A851FD8-A97D-420A-8D9E-5C8E3A2248E3Q37910056-E2B47743-81F9-4BF5-A7E6-BDD1CF34E3ADQ38059628-A16E9ADE-09D6-40E3-80D9-0EBAB2A77CC5Q38252636-8076001B-6CD4-488A-93FE-9564CCDE2432Q38579954-AF354994-E838-45AA-9FD8-87BCD072984CQ38672899-2D3ED55C-DC25-49F5-A6F7-42B87EAFA6C2Q38704228-93B1B722-4611-4F45-A6F8-845F3E2BC7E4Q38822777-B0E6E6DE-F7F0-47B6-959B-E922E5397968Q39795035-76185F81-E36D-468A-8AF2-F4B0832AD0F3Q40240319-EE9CD67B-4D0B-4386-9B36-1F58A9B53039Q40688778-9767D6E1-D532-4943-A772-A9E52FDD2791Q41574129-0B7731E7-B87A-479C-9F4A-7657B0262B23Q41659539-C11117AF-5FD7-45D2-AD35-BE4F30421B1EQ43084409-8A4BE5FD-31ED-44BC-9371-697BF03FEA4FQ43232408-6A506F40-8884-4EA3-93CC-9CF210FCED2FQ44314873-01CE01CF-2C20-44D0-AEB2-66D21B971731Q47132564-C2211C9A-40E0-4FBB-A826-21B6E3993A5E
P2860
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Molecular consequences of cyst ...... ions in the exocrine pancreas.
@ast
Molecular consequences of cyst ...... ions in the exocrine pancreas.
@en
type
label
Molecular consequences of cyst ...... ions in the exocrine pancreas.
@ast
Molecular consequences of cyst ...... ions in the exocrine pancreas.
@en
prefLabel
Molecular consequences of cyst ...... ions in the exocrine pancreas.
@ast
Molecular consequences of cyst ...... ions in the exocrine pancreas.
@en
P2093
P2860
P921
P356
P1433
P1476
Molecular consequences of cyst ...... ions in the exocrine pancreas.
@en
P2093
G Forstner
J Zielenski
P2860
P304
P356
10.1136/GUT.52.8.1159
P407
P577
2003-08-01T00:00:00Z